Follow
Shashank Masaldan
Shashank Masaldan
WEHI, Australia
Verified email at wehi.edu.au
Title
Cited by
Cited by
Year
Targeting copper in cancer therapy: ‘Copper That Cancer
D Denoyer, S Masaldan, S La Fontaine, MA Cater
Metallomics 7 (11), 1459-1476, 2015
6712015
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
S Masaldan, AI Bush, D Devos, AS Rolland, C Moreau
Free Radical Biology and Medicine 133, 221-233, 2019
3542019
Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis
S Masaldan, SAS Clatworthy, C Gamell, PM Meggyesy, AT Rigopoulos, ...
Redox biology 14, 100-115, 2018
3032018
Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis
G Shishodia, S Shukla, Y Srivastava, S Masaldan, S Mehta, S Bhambhani, ...
Molecular cancer 14, 1-13, 2015
922015
Cervical cancer stem cells selectively overexpress HPV oncoprotein E6 that controls stemness and self-renewal through upregulation of HES1
A Tyagi, K Vishnoi, S Mahata, G Verma, Y Srivastava, S Masaldan, ...
Clinical Cancer Research 22 (16), 4170-4184, 2016
912016
Cellular senescence and iron dyshomeostasis in Alzheimer’s disease
S Masaldan, AA Belaidi, S Ayton, AI Bush
Pharmaceuticals 12 (2), 93, 2019
762019
Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution
D Denoyer, HB Pearson, SAS Clatworthy, ZM Smith, PS Francis, ...
Oncotarget 7 (24), 37064, 2016
712016
Redox active metals in neurodegenerative diseases
K Acevedo, S Masaldan, CM Opazo, AI Bush
JBIC Journal of Biological Inorganic Chemistry 24, 1141-1157, 2019
682019
Characterization of selenium compounds for anti-ferroptotic activity in neuronal cells and after cerebral ischemia–reperfusion injury
QZ Tuo, S Masaldan, A Southon, C Mawal, S Ayton, AI Bush, P Lei, ...
Neurotherapeutics 18 (4), 2682-2691, 2021
462021
Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy
AA Belaidi, S Masaldan, A Southon, P Kalinowski, K Acevedo, ...
Molecular psychiatry, 1-10, 2022
432022
Copper accumulation in senescent cells: Interplay between copper transporters and impaired autophagy
S Masaldan, SAS Clatworthy, C Gamell, ZM Smith, PS Francis, D Denoyer, ...
Redox biology 16, 322-331, 2018
432018
Heterogeneous copper concentrations in cancerous human prostate tissues
D Denoyer, SAS Clatworthy, S Masaldan, PM Meggyesy, MA Cater
The Prostate 75 (14), 1510-1517, 2015
362015
Exploration of effects of emodin in selected cancer cell lines: enhanced growth inhibition by ascorbic acid and regulation of LRP1 and AR under hypoxia‐like conditions
S Masaldan, VV Iyer
Journal of Applied Toxicology 34 (1), 95-104, 2014
332014
Therapeutic targeting of mitophagy in Parkinson's disease
S Masaldan, S Callegari, G Dewson
Biochemical Society Transactions 50 (2), 783-797, 2022
222022
Dynamic reconfiguration of pro‐apoptotic BAK on membranes
JJ Sandow, IKL Tan, AS Huang, S Masaldan, JP Bernardini, AZ Wardak, ...
The EMBO Journal 40 (20), e107237, 2021
212021
Antioxidant and antiproliferative activities of methanolic extract of Aloe vera leaves in human cancer cell lines
S Masaldan, VV Iyer
J. Pharm. Res 4 (8), 2791-2796, 2011
142011
Copper ionophores as novel antiobesity therapeutics
PM Meggyesy, S Masaldan, SAS Clatworthy, I Volitakis, DJ Eyckens, ...
Molecules 25 (21), 4957, 2020
132020
Guidelines for the use and interpretation of assays for monitoring autophagy .
J Quadrilatero, DW Walker, MJ Walker, SA Walker, J Walter, ...
Autophagy, 2021
2021
Investigating metal aberrations in cellular senescence
S Masaldan
Deakin University, 2017
2017
Investigating metal aberrations in cancer: from basic science to therapeutic enquiry
S Masaldan, D Denoyer, M Cater
Deakin University, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20